TP53 and neoplasm: Array profiling studies revealed a global deregulation of p53 pathway activation in Non Responder versus Responder tumors (Figure S3A in Additional file1), potentially affecting DNA damage-induced cell death, cell cycle transitions, and tumor metabolic reprogramming (Figure S3B in Additional file1).